MedTrace Logo

Cardiac Arrest in Residential Areas With Mobile First-responder Activation

NCT04446585 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2023-09-15

No results posted yet for this study

Summary

The study aims to increase proportions of bystander defibrillation during out-of-hospital cardiac arrest (hereof referred to as cardiac arrest) in residential areas with a high density of cardiac arrests. The intervention consists of Automated External Defibrillators (AEDs) and residents' involvement in resuscitation through training and enrollment as citizen responders.

Conditions

  • Out-Of-Hospital Cardiac Arrest

Interventions

DEVICE

Automated External Defibrillator (AED)

Deployment of AEDs

OTHER

Training in cardiopulmonary resuscitation and AED use

Residents will undergo 30-minute courses at study start and if needed during the trial period. During the course they will also be recruited as citizen responders

OTHER

Activation of citizen responders

Citizen responders will be activated in case of suspected cardiac arrest through the heart runner app.

Sponsors & Collaborators

  • TrygFonden, Denmark

    collaborator INDUSTRY

  • Zoll Medical Corporation

    collaborator INDUSTRY

  • Danish Heart Foundation

    collaborator OTHER

  • Emergency Medical Services, Capital Region, Denmark

    lead OTHER_GOV

Principal Investigators

  • Fredrik Folke, MD, PhD · EMS Copenhagen

  • Carolina M Hansen, MD, PhD · EMS Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2027-01-31
Completion
2027-01-31
FDA Device
Yes

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04446585 on ClinicalTrials.gov